News for Biomerica, Inc. (BMRA)

Brings 20+ years of revenue growth leadership in laboratory testing, clinical diagnostics and global expansionLed successful organizational turnarounds and grow

Mr. Chin brings over 20 years of financial experience across public and private healthcare organizationsMr. Chin currently serves as CFO of Akido Labs where he

**media[647772]**

Real-World Impact: Initial data from over 360 patients shows inFoods® IBS delivered an average 48.5% reduction in gastrointestinal pain and a 49.8% reduction i

Biomerica (BMRA) submits an application for a PLA code to the AMA for its inFoods® IBS test, aiming for insurance reimbursement. Clinical trial results pub

Biomerica, Inc. (BMRA) has secured approval from the United Arab Emirates' Ministry of Health and Prevention for its Fortel Ulcer Test. This latest sanction ope

10-minute test enables detection of Helicobacter pylori, a leading cause of peptic ulcers, dyspepsia, and gastric cancerApproximately 80% of gastric cancer case

Regulatory milestone enables commercial expansion into high-need international market10-minute test detects early signs of kidney damage using a simple urine sa

**media[598042]**

U.S. stocks traded lower midway through trading, with the Dow Jones index falling over 200 points on Wednesday. The Dow traded down 0.55% to 40,145.06 while th...

Biomerica, Inc. (BMRA) has declared a reverse stock split, consolidating its shares on a 1-for-8 basis. This adjustment will take effect from April 21, 2025. Po

\n Biomerica (BMRA) will execute a 1-for-8 reverse stock split effective April 21, 2025. The split is intended to help regain compliance with Nasdaq's mini

U.S. stocks traded lower this morning, with the Nasdaq Composite falling over 2% on Wednesday. The Dow traded down 0.67% to 40,099.73 while the NASDAQ dipped 2...

\nShares Expected to Begin Trading on Split-Adjusted Basis on April 21, 2025\n\nIRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. ( BMRA) (â\u0080\u009cBi

IRVINE, Calif., April 16, 2025 (GLOBE NEWSWIRE) -- Biomerica, Inc. (NASDAQ:BMRA) (

PR NewswireBOTHELL, Wash., March 18, 2025 BOTHELL, Wash., March 18, 2025 /PRNewswire/ -- BioLife Solutions, Inc. (Nasdaq: BLFS) ("BioLife" or the "Company"

Significant Milestone: Biomerica secures IVDR (In Vitro Diagnostic Regulation) certification, ensuring compliance with stringent European Union standards and al

U.S. stock markets experienced a downturn on Thursday, with the Nasdaq Composite shedding over 170 points and ending the day at 19,338.29.

January 16, 2025 (Investorideas.com Newswire) Investorideas.com (www.investorideas.com), a go-to platform for big investing ideas for stock traders, including b...